Cigna ( (CI) ) has provided an announcement.
On April 24, 2025, The Cigna Group entered into a new $6.5 billion Revolving Credit and Letter of Credit Agreement with several banks, replacing its existing credit facilities. This agreement, which can be increased to $8 billion, is intended for general corporate purposes and includes various interest rate options and covenants, such as maintaining a leverage ratio not exceeding 0.60 to 1.00. Additionally, on April 22, 2025, Noelle Eder, the Executive Vice President and Global Chief Information Officer, resigned, effective May 16, 2025, for personal reasons. The company’s Annual Meeting of Shareholders on April 23, 2025, saw the election of eleven directors and the approval of executive compensation, among other proposals.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
Cigna’s overall stock score is driven by strong financial performance and positive earnings call, despite pressures from medical costs in the stop loss segment. Technical indicators show a positive short-term trend, but valuation remains a concern due to a relatively high P/E ratio. Corporate events further bolster confidence in future growth.
To see Spark’s full report on CI stock, click here.
More about Cigna
YTD Price Performance: 22.04%
Average Trading Volume: 1,901,081
Technical Sentiment Signal: Strong Sell
Current Market Cap: $90.92B
For detailed information about CI stock, go to TipRanks’ Stock Analysis page.